Rare
lephants
Screener
Toggle theme
S
China SXT Pharmaceuticals, Inc.
SXTC
·
Healthcare, Drug Manufacturers - General
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2022
FY2020
FY2019
FY2018
FY2017
Total Cash from Operations:
$4.7M
Line Item
Value
% of Total
Capital Expenditures
$60.9K
1.3%
Working Capital
$2.4M
51.2%
Net Cash Flow
$2.2M
47.5%
Download CSV